{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T14:01:10Z","timestamp":1785074470995,"version":"3.55.0"},"reference-count":182,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100024370","name":"Ministero dell'Istruzione dell'Universita e della Ricerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100024370","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020581","name":"Airc Italian Foundation for Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020581","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.bbcan.2026.189650","type":"journal-article","created":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T23:06:39Z","timestamp":1782774399000},"page":"189650","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Post-transcriptional regulation in cancer chemoresistance"],"prefix":"10.1016","volume":"1881","author":[{"given":"Sabrina","family":"De Lella","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franca","family":"Esposito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danilo Swann","family":"Matassa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosario","family":"Avolio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbcan.2026.189650_bb0005","doi-asserted-by":"crossref","DOI":"10.20517\/cdr.2019.10","article-title":"Drug resistance and combating drug resistance in cancer","author":"Wang","year":"2019","journal-title":"Cancer Drug Resist."},{"key":"10.1016\/j.bbcan.2026.189650_bb0010","article-title":"Understanding and targeting resistance mechanisms in cancer","volume":"4","author":"Lei","year":"2023","journal-title":"MedComm (Beijing)"},{"key":"10.1016\/j.bbcan.2026.189650_bb0015","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.cpt.2025.07.001","article-title":"Chemoresistance: the hidden barrier in cancer treatment","volume":"4","author":"Dhiman","year":"2026","journal-title":"Cancer Pathogenesis Ther."},{"key":"10.1016\/j.bbcan.2026.189650_bb0020","doi-asserted-by":"crossref","DOI":"10.1186\/s13073-025-01488-8","article-title":"DNA repair and the contribution to chemotherapy resistance","volume":"17","author":"Nesic","year":"2025","journal-title":"Genome Med."},{"key":"10.1016\/j.bbcan.2026.189650_bb0025","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.ccell.2022.08.020","article-title":"Targeting lineage plasticity overcomes chemoresistance","volume":"40","author":"Ogawa","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbcan.2026.189650_bb0030","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/s41586-019-1730-1","article-title":"A view on drug resistance in cancer","volume":"575","author":"Vasan","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2026.189650_bb0035","doi-asserted-by":"crossref","DOI":"10.1038\/s44276-025-00129-2","article-title":"Breaking barriers: we need a multidisciplinary approach to tackle cancer drug resistance","volume":"3","author":"Ingham","year":"2025","journal-title":"BJC Rep."},{"key":"10.1016\/j.bbcan.2026.189650_bb0040","doi-asserted-by":"crossref","DOI":"10.3390\/jpm15040141","article-title":"Targeted therapeutic approaches for the treatment of cancer: the future is bright","volume":"15","author":"Hadfield","year":"2025","journal-title":"J. Pers. Med."},{"key":"10.1016\/j.bbcan.2026.189650_bb0045","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/s41591-019-0407-5","article-title":"Molecular profiling of cancer patients enables personalized combination therapy: the I-PREDICT study","volume":"25","author":"Sicklick","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbcan.2026.189650_bb0050","article-title":"Peptides for dual targeting of ErbB1 and ErbB2: blocking EGFR cell signaling transduction pathways for cancer chemotherapy","volume":"17","author":"Patnaik","year":"2024","journal-title":"Curr. Mol. Pharmacol."},{"key":"10.1016\/j.bbcan.2026.189650_bb0055","doi-asserted-by":"crossref","first-page":"158","DOI":"10.2174\/0113892029296712240405053201","article-title":"Ramifications of m6A modification on ncRNAs in cancer","volume":"25","author":"Mehmood","year":"2024","journal-title":"Curr. Genomics"},{"key":"10.1016\/j.bbcan.2026.189650_bb0060","doi-asserted-by":"crossref","first-page":"212","DOI":"10.2174\/0113892029288843240402042529","article-title":"Detection and quantification of 5moU RNA modification from direct RNA sequencing data","volume":"25","author":"Li","year":"2024","journal-title":"Curr. Genomics"},{"key":"10.1016\/j.bbcan.2026.189650_bb0065","article-title":"Immunotherapy in hematologic malignancies: achievements, challenges and future prospects","volume":"8","author":"Tang","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bbcan.2026.189650_bb0070","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.crimmu.2022.05.003","article-title":"Clinically approved combination immunotherapy: current status, limitations, and future perspective","volume":"3","author":"Lu","year":"2022","journal-title":"Curr. Res. Immunol."},{"key":"10.1016\/j.bbcan.2026.189650_bb0075","doi-asserted-by":"crossref","DOI":"10.3390\/cancers17111882","article-title":"Current progress and future perspectives of RNA-based cancer vaccines: a 2025 update","volume":"17","author":"Magoola","year":"2025","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bbcan.2026.189650_bb0080","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1093\/annonc\/mdv209","article-title":"Combining immunotherapy and anticancer agents: the right path to achieve cancer cure?","volume":"26","author":"Apetoh","year":"2015","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.bbcan.2026.189650_bb0085","doi-asserted-by":"crossref","DOI":"10.3390\/biom12101365","article-title":"Cisplatin resistance: genetic and epigenetic factors involved","volume":"12","author":"Lugones","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.bbcan.2026.189650_bb0090","doi-asserted-by":"crossref","DOI":"10.3390\/cells9040828","article-title":"Cholesterol homeostasis modulates platinum sensitivity in human ovarian cancer","volume":"9","author":"Criscuolo","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.bbcan.2026.189650_bb0095","doi-asserted-by":"crossref","DOI":"10.3390\/cells13090786","article-title":"Deciphering the molecular mechanisms behind drug resistance in ovarian cancer to unlock efficient treatment options","volume":"13","author":"Nunes","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.bbcan.2026.189650_bb0100","doi-asserted-by":"crossref","DOI":"10.3892\/ijo.2023.5567","article-title":"Mechanism of multidrug resistance to chemotherapy mediated by P-glycoprotein (review)","volume":"63","author":"Tian","year":"2023","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.bbcan.2026.189650_bb0105","doi-asserted-by":"crossref","first-page":"95","DOI":"10.7555\/JBR.37.20230248","article-title":"Drug resistance mechanisms in cancers: execution of pro-survival strategies","volume":"38","author":"Dhanyamraju","year":"2024","journal-title":"J. Biomed. Res."},{"key":"10.1016\/j.bbcan.2026.189650_bb0110","article-title":"Multidrug resistance in cancer: understanding molecular mechanisms, immunoprevention and therapeutic approaches","volume":"12","author":"Bin","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbcan.2026.189650_bb0115","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/s41576-022-00556-8","article-title":"Regulation of pre-mRNA splicing: roles in physiology and disease, and therapeutic prospects","volume":"24","author":"Rogalska","year":"2023","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.bbcan.2026.189650_bb0120","article-title":"Alternative splicing in cancer drug resistance: mechanisms and therapeutic prospects (review)","volume":"55","author":"Zhu","year":"2026","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.bbcan.2026.189650_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114810","article-title":"Impact of alternative splicing on mechanisms of resistance to anticancer drugs","volume":"193","author":"Reviejo","year":"2021","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbcan.2026.189650_bb0130","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1126\/science.adn8105","article-title":"Transcriptome-wide splicing network reveals specialized regulatory functions of the core spliceosome","volume":"386","author":"Rogalska","year":"2024","journal-title":"Science"},{"key":"10.1016\/j.bbcan.2026.189650_bb0135","doi-asserted-by":"crossref","first-page":"3185","DOI":"10.1038\/s41388-018-0655-8","article-title":"TGF-\u03b2-induced alternative splicing of TAK1 promotes EMT and drug resistance","volume":"38","author":"Tripathi","year":"2019","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2026.189650_bb0140","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1080\/14728222.2017.1349755","article-title":"TRAP1: a viable therapeutic target for future cancer treatments?","volume":"21","author":"Lettini","year":"2017","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.bbcan.2026.189650_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellin.2024.100170","article-title":"LUC7L3 is a downstream factor of SRSF1 and prevents genomic instability","volume":"3","author":"Zhang","year":"2024","journal-title":"Cell Insight."},{"key":"10.1016\/j.bbcan.2026.189650_bb0150","doi-asserted-by":"crossref","DOI":"10.1261\/rna.080588.125","article-title":"The molecular chaperone TRAP1 promotes translation of Luc7l3 mRNA to enhance ovarian cancer cell proliferation","author":"De Lella","year":"2025","journal-title":"RNA"},{"key":"10.1016\/j.bbcan.2026.189650_bb0155","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/path.4715","article-title":"Altered ratios of pro- and anti-angiogenic VEGF-A variants and pericyte expression of DLL4 disrupt vascular maturation in infantile haemangioma","volume":"239","author":"Ye","year":"2016","journal-title":"J. Pathol."},{"key":"10.1016\/j.bbcan.2026.189650_bb0160","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1002\/jcb.29366","article-title":"SRSF1-dependent alternative splicing attenuates BIN1 expression in non-small cell lung cancer","volume":"121","author":"Wang","year":"2020","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.bbcan.2026.189650_bb0165","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-59823-5","article-title":"VEGF-A165b levels are reduced in breast cancer patients at primary diagnosis but increase after completion of cancer treatment","volume":"10","author":"Karsten","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbcan.2026.189650_bb0170","doi-asserted-by":"crossref","DOI":"10.3390\/cancers17081381","article-title":"Aberrant splicing as a mechanism for resistance to cancer therapies","volume":"17","author":"Duzgun","year":"2025","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bbcan.2026.189650_bb0175","article-title":"SRSF1-mediated alternative splicing regulates bladder cancer progression and cisplatin sensitivity through HIF1A\/BNIP3\/mitophagy axis","volume":"23","author":"Wu","year":"2025","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.bbcan.2026.189650_bb0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/15476286.2025.2470511","article-title":"RNA-binding proteins as therapeutic targets in cancer","volume":"22","author":"Jungfleisch","year":"2025","journal-title":"RNA Biol."},{"key":"10.1016\/j.bbcan.2026.189650_bb0185","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1038\/s41375-025-02740-1","article-title":"SF3B1-mutant models of RNA mis-splicing uncover UBA1 as a therapeutic target in myelodysplastic neoplasms","volume":"39","author":"Thier","year":"2025","journal-title":"Leukemia"},{"key":"10.1016\/j.bbcan.2026.189650_bb0190","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2019.00268","article-title":"Diverse mechanisms of BRAF inhibitor resistance in melanoma identified in clinical and preclinical studies","volume":"9","author":"Luebker","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbcan.2026.189650_bb0195","doi-asserted-by":"crossref","DOI":"10.1101\/gr.280304.124","article-title":"Alternative splicing generates HER2 isoform diversity underlying antibody\u2013drug conjugate resistance in breast cancer","author":"Guardia","year":"2025","journal-title":"Genome Res."},{"key":"10.1016\/j.bbcan.2026.189650_bb0200","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1038\/s41467-017-01255-3","article-title":"Endosomal phosphatidylserine is critical for the YAP signalling pathway in proliferating cells","volume":"8","author":"Matsudaira","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbcan.2026.189650_bb0205","doi-asserted-by":"crossref","first-page":"4549","DOI":"10.1038\/s41388-025-03599-3","article-title":"Emerging roles of RNA-binding protein hnRNPM in alternative splicing regulation and UTMD mediated sh-hnRNPM\/CMBs suppress the proliferation of colorectal cancer","volume":"44","author":"Hu","year":"2025","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2026.189650_bb0210","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1016\/j.cell.2026.01.006","article-title":"RNA modifications in gene regulation: functions and pathways","volume":"189","author":"Wei","year":"2026","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2026.189650_bb0215","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/s41576-023-00645-2","article-title":"RNA modifications in physiology and disease: towards clinical applications","volume":"25","author":"Delaunay","year":"2024","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.bbcan.2026.189650_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110813","article-title":"SRSF3-mediated regulation of N6-methyladenosine modification-related lncRNA ANRIL splicing promotes resistance of pancreatic cancer to gemcitabine","volume":"39","author":"Wang","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbcan.2026.189650_bb0225","doi-asserted-by":"crossref","DOI":"10.1093\/narcan\/zcad054","article-title":"m6A epitranscriptome analysis reveals differentially methylated transcripts that drive early chemoresistance in bladder cancer","volume":"5","author":"Hodara","year":"2023","journal-title":"NAR Cancer."},{"key":"10.1016\/j.bbcan.2026.189650_bb0230","doi-asserted-by":"crossref","DOI":"10.1186\/s12967-025-06938-w","article-title":"Mechanistic insights into the role of RNA demethylase ALKBH5 in malignant tumor therapy","volume":"23","author":"An","year":"2025","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.bbcan.2026.189650_bb0235","doi-asserted-by":"crossref","DOI":"10.1186\/s13046-021-02088-1","article-title":"ALKBH5-HOXA10 loop-mediated JAK2 m6A demethylation and cisplatin resistance in epithelial ovarian cancer","volume":"40","author":"Nie","year":"2021","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189650_bb0240","doi-asserted-by":"crossref","DOI":"10.1172\/JCI185149","article-title":"KRAS mutants confer platinum resistance by regulating ALKBH5 posttranslational modifications in lung cancer","volume":"135","author":"Yu","year":"2025","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbcan.2026.189650_bb0245","article-title":"LncRNA SOX2OT promotes temozolomide resistance by elevating SOX2 expression via ALKBH5-mediated epigenetic regulation in glioblastoma","volume":"11","author":"Liu","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbcan.2026.189650_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2024.116807","article-title":"ALKBH5 regulates paclitaxel resistance in NSCLC via inhibiting CEMIP-mediated EMT","volume":"483","author":"Gao","year":"2024","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.bbcan.2026.189650_bb0255","article-title":"5-Methylcytosine RNA modification and its roles in cancer and cancer chemotherapy resistance","volume":"23","author":"Li","year":"2025","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.bbcan.2026.189650_bb0260","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s10495-022-01779-0","article-title":"DNMT2\/TRDMT1 gene knockout compromises doxorubicin-induced unfolded protein response and sensitizes cancer cells to ER stress-induced apoptosis","volume":"28","author":"Adamczyk-Grochala","year":"2023","journal-title":"Apoptosis"},{"key":"10.1016\/j.bbcan.2026.189650_bb0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.102975","article-title":"Epigenetically upregulated NSUN2 confers ferroptosis resistance in endometrial cancer via m5C modification of SLC7A11 mRNA","volume":"69","author":"Chen","year":"2024","journal-title":"Redox Biol."},{"key":"10.1016\/j.bbcan.2026.189650_bb0270","doi-asserted-by":"crossref","DOI":"10.1186\/s11658-025-00781-z","article-title":"NSUN2\u2013tRNAVal\u2212CAC-axis-regulated codon-biased translation drives triple-negative breast cancer glycolysis and progression","volume":"30","author":"Wang","year":"2025","journal-title":"Cell. Mol. Biol. Lett."},{"key":"10.1016\/j.bbcan.2026.189650_bb0275","article-title":"Dysregulated selective translation in cancer: the pivotal functions of RNA-binding proteins and emerging therapeutic avenues","volume":"1881","author":"Hu","year":"2026","journal-title":"Biochim. Biophys. Acta (BBA) - Rev. Cancer"},{"key":"10.1016\/j.bbcan.2026.189650_bb0280","doi-asserted-by":"crossref","DOI":"10.1186\/s12935-022-02788-4","article-title":"Regulation of mitochondrial complex III activity and assembly by TRAP1 in cancer cells","volume":"22","author":"Matassa","year":"2022","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.bbcan.2026.189650_bb0285","doi-asserted-by":"crossref","first-page":"e851","DOI":"10.1038\/cddis.2013.379","article-title":"Translational control in the stress adaptive response of cancer cells: a novel role for the heat shock protein TRAP1","volume":"4","author":"Matassa","year":"2013","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbcan.2026.189650_bb0290","doi-asserted-by":"crossref","DOI":"10.3892\/ijo.2022.5369","article-title":"TRAP1 regulates the response of colorectal cancer cells to hypoxia and inhibits ribosome biogenesis under conditions of oxygen deprivation","volume":"60","author":"Bruno","year":"2022","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.bbcan.2026.189650_bb0295","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1101\/gr.277755.123","article-title":"Cytosolic and mitochondrial translation elongation are coordinated through the molecular chaperone TRAP1 for the synthesis and import of mitochondrial proteins","volume":"33","author":"Avolio","year":"2023","journal-title":"Genome Res."},{"key":"10.1016\/j.bbcan.2026.189650_bb0300","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.797265","article-title":"Targeting mitochondrial protein expression as a future approach for cancer therapy","volume":"11","author":"Criscuolo","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbcan.2026.189650_bb0305","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-16352-z","article-title":"Translational control of breast cancer plasticity","volume":"11","author":"Jewer","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbcan.2026.189650_bb0310","doi-asserted-by":"crossref","first-page":"10734","DOI":"10.1021\/acs.jmedchem.3c00917","article-title":"Design of cell-permeable inhibitors of eukaryotic translation initiation factor 4E (eIF4E) for inhibiting aberrant cap-dependent translation in cancer","volume":"66","author":"C\u00e1rdenas","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbcan.2026.189650_bb0315","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1261\/rna.080340.124","article-title":"eIF4F-mediated dysregulation of mRNA translation in cancer","volume":"31","author":"Amiri","year":"2025","journal-title":"RNA"},{"key":"10.1016\/j.bbcan.2026.189650_bb0320","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/nrc.2016.27","article-title":"New frontiers in translational control of the cancer genome","volume":"16","author":"Truitt","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbcan.2026.189650_bb0325","doi-asserted-by":"crossref","DOI":"10.1038\/s41523-024-00664-0","article-title":"Altered ribosomal profile in acquired resistance and reversal associates with pathological response to chemotherapy in inflammatory breast cancer","volume":"10","author":"Devi","year":"2024","journal-title":"NPJ Breast Cancer."},{"key":"10.1016\/j.bbcan.2026.189650_bb0330","doi-asserted-by":"crossref","first-page":"3206","DOI":"10.1038\/s41388-020-1210-y","article-title":"Phosphorylation independent eIF4E translational reprogramming of selective mRNAs determines tamoxifen resistance in breast cancer","volume":"39","author":"Gong","year":"2020","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2026.189650_bb0335","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15051444","article-title":"Rapamycin-induced feedback activation of eIF4E-EIF4A dependent mRNA translation in pancreatic cancer","volume":"15","author":"Nguyen","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bbcan.2026.189650_bb0340","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1038\/s41568-023-00567-5","article-title":"The role of eIF4F-driven mRNA translation in regulating the tumour microenvironment","volume":"23","author":"Bartish","year":"2023","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbcan.2026.189650_bb0345","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1717439115","article-title":"Translational control in the tumor microenvironment promotes lung metastasis: phosphorylation of eIF4E in neutrophils","volume":"115","author":"Robichaud","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbcan.2026.189650_bb0350","doi-asserted-by":"crossref","DOI":"10.1186\/s11658-024-00674-7","article-title":"Elongation factor 2 in cancer: a promising therapeutic target in protein translation","volume":"29","author":"Jia","year":"2024","journal-title":"Cell. Mol. Biol. Lett."},{"key":"10.1016\/j.bbcan.2026.189650_bb0355","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.cellsig.2016.01.005","article-title":"Elongation factor 2 kinase promotes cell survival by inhibiting protein synthesis without inducing autophagy","volume":"28","author":"CEJ","year":"2016","journal-title":"Cell. Signal."},{"key":"10.1016\/j.bbcan.2026.189650_bb0360","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2025.177746","article-title":"Targeting eEF2K induces oxidative stress and sensitizes cancer cells to ferroptosis induction","volume":"1001","author":"Ye","year":"2025","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbcan.2026.189650_bb0365","article-title":"The eEF2 kinase coordinates the DNA damage response to cisplatin by supporting p53 activation","volume":"15","author":"JKM","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbcan.2026.189650_bb0370","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/s00109-020-01917-8","article-title":"Eukaryotic elongation factor-2 kinase (eEF2K) signaling in tumor and microenvironment as a novel molecular target","volume":"98","author":"Karakas","year":"2020","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.bbcan.2026.189650_bb0375","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-025-07803-w","article-title":"eEF2K is a poor prognostic factor and novel molecular target in pancreatic cancer: regulating tumor growth and progression via the tumor microenvironment","volume":"16","author":"Karakas","year":"2025","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbcan.2026.189650_bb0380","article-title":"eEF2K as an important kinase associated with cancer survival and prognosis","volume":"14","author":"Wang","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbcan.2026.189650_bb0385","doi-asserted-by":"crossref","DOI":"10.1093\/narcan\/zcae012","article-title":"The impact of tRNA modifications on translation in cancer: identifying novel therapeutic avenues","volume":"6","author":"A\u00f1azco-Guenkova","year":"2024","journal-title":"NAR Cancer."},{"key":"10.1016\/j.bbcan.2026.189650_bb0390","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1016\/j.cell.2016.05.046","article-title":"Modulated expression of specific tRNAs drives gene expression and cancer progression","volume":"165","author":"Goodarzi","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2026.189650_bb0395","first-page":"1484","article-title":"Two isoleucyl tRNAs that decode synonymous codons divergently regulate breast cancer metastatic growth by controlling translation of proliferation-regulating genes","volume":"3","author":"Earnest-Noble","year":"2022","journal-title":"Nat. Can."},{"key":"10.1016\/j.bbcan.2026.189650_bb0400","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.molmed.2022.09.007","article-title":"Dysfunctional tRNA reprogramming and codon-biased translation in cancer","volume":"28","author":"Dedon","year":"2022","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.bbcan.2026.189650_bb0405","doi-asserted-by":"crossref","first-page":"9075","DOI":"10.1038\/s41467-025-64144-0","article-title":"ALKBH8-mediated codon-specific translation promotes colorectal tumorigenesis","volume":"16","author":"Qian","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbcan.2026.189650_bb0410","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/s41586-018-0243-7","article-title":"Codon-specific translation reprogramming promotes resistance to targeted therapy","volume":"558","author":"Rapino","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2026.189650_bb0415","doi-asserted-by":"crossref","first-page":"5426","DOI":"10.1093\/nar\/gkab187","article-title":"RNA G-quadruplexes (rG4s): genomics and biological functions","volume":"49","author":"Lyu","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbcan.2026.189650_bb0420","doi-asserted-by":"crossref","DOI":"10.1093\/narcan\/zcae025","article-title":"The shaping of mRNA translation plasticity by RNA G-quadruplexes in cancer progression and therapy resistance","volume":"6","author":"Cammas","year":"2024","journal-title":"NAR Cancer."},{"key":"10.1016\/j.bbcan.2026.189650_bb0425","doi-asserted-by":"crossref","first-page":"16793","DOI":"10.18632\/oncotarget.7589","article-title":"hnRNP A1-mediated translational regulation of the G quadruplex-containing RON receptor tyrosine kinase mRNA linked to tumor progression","volume":"7","author":"Cammas","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbcan.2026.189650_bb0430","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1038\/onc.2016.282","article-title":"The novel G-quadruplex-containing long non-coding RNA GSEC antagonizes DHX36 and modulates colon cancer cell migration","volume":"36","author":"Matsumura","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2026.189650_bb0435","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1038\/s41591-018-0217-1","article-title":"Translational control of tumor immune escape via the eIF4F\u2013STAT1\u2013PD-L1 axis in melanoma","volume":"24","author":"Cerezo","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbcan.2026.189650_bb0440","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23020743","article-title":"G-quadruplex regulation of VEGFA mRNA translation by RBM4","volume":"23","author":"Niu","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbcan.2026.189650_bb0445","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-16168-x","article-title":"HnRNP H\/F drive RNA G-quadruplex-mediated translation linked to genomic instability and therapy resistance in glioblastoma","volume":"11","author":"Herviou","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbcan.2026.189650_bb0450","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/nature13485","article-title":"RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer","volume":"513","author":"Wolfe","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2026.189650_bb0455","doi-asserted-by":"crossref","first-page":"4727","DOI":"10.1093\/nar\/gks068","article-title":"5\u2019-UTR RNA G-quadruplexes: translation regulation and targeting","volume":"40","author":"Bugaut","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbcan.2026.189650_bb0460","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.108692","article-title":"Chelerythrine may bind to KRAS mRNA G-quadruplex in the cisplatin-resistant non-small cell lung cancer cells","volume":"163","author":"Zhou","year":"2025","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bbcan.2026.189650_bb0465","doi-asserted-by":"crossref","DOI":"10.1007\/s10142-025-01656-4","article-title":"RNA G-quadruplexes: emerging regulators of gene expression and therapeutic targets","volume":"25","author":"Ruzi","year":"2025","journal-title":"Funct. Integr. Genom."},{"key":"10.1016\/j.bbcan.2026.189650_bb0470","doi-asserted-by":"crossref","DOI":"10.1038\/s41420-023-01352-x","article-title":"Novel roles of RNA-binding proteins in drug resistance of breast cancer: from molecular biology to targeting therapeutics","volume":"9","author":"Cen","year":"2023","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.bbcan.2026.189650_bb0475","doi-asserted-by":"crossref","first-page":"13551","DOI":"10.1074\/jbc.M117.780973","article-title":"Post-transcriptional regulation of ERBB2 by miR26a\/b and HuR confers resistance to tamoxifen in estrogen receptor-positive breast cancer cells","volume":"292","author":"Tan","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbcan.2026.189650_bb0480","article-title":"The emerging role of IGF2BP2 in cancer therapy resistance: from molecular mechanism to future potential","volume":"25","author":"Li","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbcan.2026.189650_bb0485","article-title":"Targeting IGF2BP3 in cancer","volume":"24","author":"Liu","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbcan.2026.189650_bb0490","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2024.116555","article-title":"Role of the RNA binding protein IGF2BP1 in cancer multidrug resistance","volume":"230","author":"Gola","year":"2024","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbcan.2026.189650_bb0495","doi-asserted-by":"crossref","DOI":"10.1186\/s12967-022-03549-7","article-title":"IGF2BP1-regulated expression of ERR\u03b1 is involved in metabolic reprogramming of chemotherapy resistant osteosarcoma cells","volume":"20","author":"He","year":"2022","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.bbcan.2026.189650_bb0500","doi-asserted-by":"crossref","DOI":"10.3892\/or.2024.8801","article-title":"The role of lncRNA binding to RNA-binding proteins to regulate mRNA stability in cancer progression and drug resistance mechanisms (review)","volume":"52","author":"Zhang","year":"2024","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.bbcan.2026.189650_bb0505","doi-asserted-by":"crossref","first-page":"17204","DOI":"10.3390\/ijms140817204","article-title":"Post-transcriptional controls by ribonucleoprotein complexes in the acquisition of drug resistance","volume":"14","author":"Kang","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbcan.2026.189650_bb0510","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.devcel.2015.10.005","article-title":"Global analysis of mRNA, translation, and protein localization: local translation is a key regulator of cell protrusions","volume":"35","author":"Mardakheh","year":"2015","journal-title":"Dev. Cell"},{"key":"10.1016\/j.bbcan.2026.189650_bb0515","doi-asserted-by":"crossref","DOI":"10.3390\/ph16081114","article-title":"Surmounting cancer drug resistance: new perspective on RNA-binding proteins","volume":"16","author":"Feng","year":"2023","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.bbcan.2026.189650_bb0520","doi-asserted-by":"crossref","DOI":"10.1186\/s12967-023-04373-3","article-title":"RNA binding protein: coordinated expression between the nuclear and mitochondrial genomes in tumors","volume":"21","author":"Ma","year":"2023","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.bbcan.2026.189650_bb0525","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26178139","article-title":"Discovery of small molecules that inhibit MYC mRNA translation through hnRNPK and induction of stress granule-mediated mRNA relocalization","volume":"26","author":"Sheinberger","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbcan.2026.189650_bb0530","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.devcel.2020.10.006","article-title":"Subcellular mRNA localization regulates ribosome biogenesis in migrating cells","volume":"55","author":"Dermit","year":"2020","journal-title":"Dev. Cell"},{"key":"10.1016\/j.bbcan.2026.189650_bb0535","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1016\/j.molcel.2023.06.036","article-title":"mRNA location and translation rate determine protein targeting to dual destinations","volume":"83","author":"Gasparski","year":"2023","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbcan.2026.189650_bb0540","doi-asserted-by":"crossref","DOI":"10.1186\/s12935-024-03549-1","article-title":"Comprehensive review of LncRNA-mediated therapeutic resistance in non-small cell lung cancer","volume":"24","author":"Ge","year":"2024","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.bbcan.2026.189650_bb0545","doi-asserted-by":"crossref","DOI":"10.3390\/biom15101393","article-title":"The life of microRNAs: biogenesis, function and decay in cancer","volume":"15","author":"Ding","year":"2025","journal-title":"Biomolecules"},{"key":"10.1016\/j.bbcan.2026.189650_bb0550","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/MS9.0000000000002761","article-title":"Circular RNAs: history, metabolism, mechanisms of function, and regulatory roles at a glance","volume":"87","author":"Karimi","year":"2025","journal-title":"Ann. Med. Surg."},{"key":"10.1016\/j.bbcan.2026.189650_bb0555","doi-asserted-by":"crossref","first-page":"720","DOI":"10.7150\/jca.102148","article-title":"A novel competing endogenous RNA network reveals potential mechanisms and biomarkers of chemoresistance in lung adenocarcinoma","volume":"16","author":"Liu","year":"2025","journal-title":"J. Cancer"},{"key":"10.1016\/j.bbcan.2026.189650_bb0560","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1093\/carcin\/bgad065","article-title":"Construction and identification of lncRNA\/circRNA-coregulated ceRNA networks in gemcitabine-resistant bladder carcinoma","volume":"44","author":"Pan","year":"2023","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.bbcan.2026.189650_bb0565","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1186\/s13018-021-02631-y","article-title":"Hsa_circ_0004674 promotes osteosarcoma doxorubicin resistance by regulating the miR-342-3p\/FBN1 axis","volume":"16","author":"Bai","year":"2021","journal-title":"J. Orthop. Surg. Res."},{"key":"10.1016\/j.bbcan.2026.189650_bb0570","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s10147-022-02122-y","article-title":"CircRNA PVT1 promotes proliferation and chemoresistance of osteosarcoma cells via the miR-24-3p\/KLF8 axis","volume":"27","author":"Wang","year":"2022","journal-title":"Int. J. Clin. Oncol."},{"key":"10.1016\/j.bbcan.2026.189650_bb0575","article-title":"Circular RNA La-related RNA-binding protein 4 correlates with reduced tumor stage, as well as better prognosis, and promotes chemosensitivity to doxorubicin in breast cancer","volume":"34","author":"Zhang","year":"2020","journal-title":"J. Clin. Lab. Anal."},{"key":"10.1016\/j.bbcan.2026.189650_bb0580","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s13045-022-01345-w","article-title":"CircRNA-CREIT inhibits stress granule assembly and overcomes doxorubicin resistance in TNBC by destabilizing PKR","volume":"15","author":"Wang","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.bbcan.2026.189650_bb0585","doi-asserted-by":"crossref","DOI":"10.1186\/s12951-024-02295-w","article-title":"CircNUP50 is a novel therapeutic target that promotes cisplatin resistance in ovarian cancer by modulating p53 ubiquitination","volume":"22","author":"Zhu","year":"2024","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.bbcan.2026.189650_bb0590","doi-asserted-by":"crossref","DOI":"10.1186\/s12964-024-01952-9","article-title":"The role of circRNAs in resistance to doxorubicin","volume":"22","author":"Sanati","year":"2024","journal-title":"Cell Commun. Signal"},{"key":"10.1016\/j.bbcan.2026.189650_bb0595","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14041090","article-title":"The roles of microRNAs in cancer multidrug resistance","volume":"14","author":"Pavl\u00edkov\u00e1","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bbcan.2026.189650_bb0600","doi-asserted-by":"crossref","DOI":"10.3892\/etm.2019.8376","article-title":"Effects of miR-21 on proliferation and apoptosis of WT cells via PTEN\/Akt pathway","author":"Zhang","year":"2019","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.bbcan.2026.189650_bb0605","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2024.102221","article-title":"LNA-i-miR-221 activity in colorectal cancer: a reverse translational investigation","volume":"35","author":"Ali","year":"2024","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.bbcan.2026.189650_bb0610","article-title":"MicroRNA-34 family: a potential tumor suppressor and therapeutic candidate in cancer","volume":"38","author":"Zhang","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189650_bb0615","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154631","article-title":"The emerging role of microRNA-126 as a potential therapeutic target in cancer: a comprehensive review","volume":"248","author":"Jalil","year":"2023","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.bbcan.2026.189650_bb0620","doi-asserted-by":"crossref","DOI":"10.1186\/s13046-025-03391-x","article-title":"MicroRNA in cancer therapy: breakthroughs and challenges in early clinical applications","volume":"44","author":"Martino","year":"2025","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189650_bb0625","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202400841R","article-title":"Non-canonical <scp>RNA<\/scp> -binding protein <scp>ANXA11<\/scp> regulates <scp>microRNA<\/scp> resorting into small extracellular vesicles to mediate cisplatin resistance","volume":"38","author":"Zhang","year":"2024","journal-title":"FASEB J."},{"key":"10.1016\/j.bbcan.2026.189650_bb0630","doi-asserted-by":"crossref","DOI":"10.1007\/s00395-020-0783-5","article-title":"Mitochondrial noncoding RNA-regulatory network in cardiovascular disease","volume":"115","author":"Jusic","year":"2020","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.bbcan.2026.189650_bb0635","article-title":"Mitochondria encoded non-coding RNAs in cell physiology","volume":"9","author":"Liu","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.bbcan.2026.189650_bb0640","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.1158\/0008-5472.CAN-20-3145","article-title":"LncRNA SAMMSON mediates adaptive resistance to RAF inhibition in BRAF-mutant melanoma cells","volume":"81","author":"Han","year":"2021","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189650_bb0645","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1472804","article-title":"Mitochondria-associated non-coding RNAs and their impact on drug resistance","volume":"16","author":"An","year":"2025","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bbcan.2026.189650_bb0650","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nrm.2017.130","article-title":"A brave new world of RNA-binding proteins","volume":"19","author":"Hentze","year":"2018","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bbcan.2026.189650_bb0655","doi-asserted-by":"crossref","first-page":"4811","DOI":"10.1016\/j.cell.2025.06.021","article-title":"Rethinking RNA-binding proteins: riboregulation challenges prevailing views","volume":"188","author":"Hentze","year":"2025","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2026.189650_bb0660","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1038\/nature08470","article-title":"Preserving electron spin coherence in solids by optimal dynamical decoupling","volume":"461","author":"Du","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2026.189650_bb0665","doi-asserted-by":"crossref","DOI":"10.1038\/s41420-025-02646-y","article-title":"RNA-mediated inhibition of mitochondrial SHMT2 impairs cancer cell proliferation","volume":"11","author":"Liberati","year":"2025","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.bbcan.2026.189650_bb0670","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111233","article-title":"SHMT2-mediated mitochondrial serine metabolism drives 5-FU resistance by fueling nucleotide biosynthesis","volume":"40","author":"Pranzini","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbcan.2026.189650_bb0675","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1016\/j.molcel.2024.06.016","article-title":"Structure-based mechanism of riboregulation of the metabolic enzyme SHMT1","volume":"84","author":"Spizzichino","year":"2024","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbcan.2026.189650_bb0680","doi-asserted-by":"crossref","first-page":"3981","DOI":"10.7150\/ijbs.63556","article-title":"Enolase 1, a moonlighting protein, as a potential target for cancer treatment","volume":"17","author":"Qiao","year":"2021","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.bbcan.2026.189650_bb0685","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s10549-009-0492-0","article-title":"Increased expression of enolase \u03b1 in human breast cancer confers tamoxifen resistance in human breast cancer cells","volume":"121","author":"Tu","year":"2010","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.bbcan.2026.189650_bb0690","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.942064","article-title":"Relationship between metabolic reprogramming and drug resistance in breast cancer","volume":"12","author":"Lv","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbcan.2026.189650_bb0695","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1016\/j.molcel.2022.05.019","article-title":"Riboregulation of Enolase 1 activity controls glycolysis and embryonic stem cell differentiation","volume":"82","author":"Huppertz","year":"2022","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbcan.2026.189650_bb0700","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gky873","article-title":"Protein Syndesmos is a novel RNA-binding protein that regulates primary cilia formation","author":"Avolio","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbcan.2026.189650_bb0705","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/nature21358","article-title":"TIRR regulates 53BP1 by masking its histone methyl-lysine binding function","volume":"543","author":"Dran\u00e9","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2026.189650_bb0710","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-52862-w","article-title":"NEAT1 modulates the TIRR\/53BP1 complex to maintain genome integrity","volume":"15","author":"Kilgas","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbcan.2026.189650_bb0715","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/s41576-020-00302-y","article-title":"RNA-binding proteins in human genetic disease","volume":"22","author":"Gebauer","year":"2021","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.bbcan.2026.189650_bb0720","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/s41576-019-0093-7","article-title":"Integrative single-cell analysis","volume":"20","author":"Stuart","year":"2019","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.bbcan.2026.189650_bb0725","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/s41586-021-03536-w","article-title":"Small-molecule inhibition of METTL3 as a strategy against myeloid leukaemia","volume":"593","author":"Yankova","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2026.189650_bb0730","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.ccell.2020.02.004","article-title":"m6A modification in coding and non-coding RNAs: roles and therapeutic implications in cancer","volume":"37","author":"Huang","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbcan.2026.189650_bb0735","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1158\/0008-5472.CAN-14-2789","article-title":"Targeting the eIF4F translation initiation complex: a critical nexus for cancer development","volume":"75","author":"Pelletier","year":"2015","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189650_bb0740","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1038\/s41416-020-01205-9","article-title":"Targeting eIF4F translation initiation complex with SBI-756 sensitises B lymphoma cells to venetoclax","volume":"124","author":"Herzog","year":"2021","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbcan.2026.189650_bb0745","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/nm.4493","article-title":"H3B-8800, an orally available small-molecule splicing modulator, induces lethality in spliceosome-mutant cancers","volume":"24","author":"Seiler","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbcan.2026.189650_bb0750","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2024.1308102","article-title":"RNA binding proteins in cancer chemotherapeutic drug resistance","volume":"12","author":"Vembuli","year":"2024","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.bbcan.2026.189650_bb0755","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/nrg3813","article-title":"A census of human RNA-binding proteins","volume":"15","author":"Gerstberger","year":"2014","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.bbcan.2026.189650_bb0760","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.4161\/cc.9.7.11164","article-title":"miR-519 suppresses tumor growth by reducing HuR levels","volume":"9","author":"Abdelmohsen","year":"2010","journal-title":"Cell Cycle"},{"key":"10.1016\/j.bbcan.2026.189650_bb0765","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1021\/cb500851u","article-title":"Identification and validation of novel small molecule disruptors of HuR-mRNA interaction","volume":"10","author":"Wu","year":"2015","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.bbcan.2026.189650_bb0770","doi-asserted-by":"crossref","first-page":"9514","DOI":"10.1093\/nar\/gkx623","article-title":"Regulation of HuR structure and function by dihydrotanshinone-I","volume":"45","author":"Lal","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbcan.2026.189650_bb0775","article-title":"Inhibition of RNA-binding proteins enhances immunotherapy in ovarian cancer","volume":"10","author":"Bley","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bbcan.2026.189650_bb0780","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1016\/j.ymthe.2021.04.032","article-title":"Therapeutic targeting of RNA-binding protein by RNA-PROTAC","volume":"29","author":"Li","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.bbcan.2026.189650_bb0785","doi-asserted-by":"crossref","DOI":"10.1038\/s41420-021-00598-7","article-title":"RNA-binding protein 39: a promising therapeutic target for cancer","volume":"7","author":"Xu","year":"2021","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.bbcan.2026.189650_bb0790","doi-asserted-by":"crossref","first-page":"3879","DOI":"10.1021\/jacsau.5c00551","article-title":"Druglike molecular degraders of the oncogenic RNA-binding protein HuR","volume":"5","author":"Kassabri","year":"2025","journal-title":"JACS Au"},{"key":"10.1016\/j.bbcan.2026.189650_bb0795","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-026-10613-5","article-title":"Molecular glue degraders of HuR suppress BRAF-mutant colorectal cancer","author":"Lu","year":"2026","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2026.189650_bb0800","doi-asserted-by":"crossref","DOI":"10.1002\/mabi.202400427","article-title":"PROTAC and molecular glue degraders of the oncogenic RNA binding protein Lin28","volume":"25","author":"Kashkush","year":"2025","journal-title":"Macromol. Biosci."},{"key":"10.1016\/j.bbcan.2026.189650_bb0805","article-title":"Targeted protein degradation: mechanisms, strategies and application","volume":"7","author":"Zhao","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bbcan.2026.189650_bb0810","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1038\/s41416-020-0802-1","article-title":"Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours","volume":"122","author":"Hong","year":"2020","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbcan.2026.189650_bb0815","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/S1470-2045(17)30621-6","article-title":"Safety and activity of microRNA-loaded minicells in patients with recurrent malignant pleural mesothelioma: a first-in-man, phase 1, open-label, dose-escalation study","volume":"18","author":"van Zandwijk","year":"2017","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.bbcan.2026.189650_bb0820","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/s41573-020-0075-7","article-title":"Advances in oligonucleotide drug delivery","volume":"19","author":"Roberts","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bbcan.2026.189650_bb0825","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/s41586-019-1730-1","article-title":"A view on drug resistance in cancer","volume":"575","author":"Vasan","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2026.189650_bb0830","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/nrc.2017.109","article-title":"Targeting mutant p53 for efficient cancer therapy","volume":"18","author":"VJN","year":"2018","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbcan.2026.189650_bb0835","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/nrm2147","article-title":"p53 in health and disease","volume":"8","author":"Vousden","year":"2007","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bbcan.2026.189650_bb0840","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/s41568-018-0005-8","article-title":"Revisiting the role of ABC transporters in multidrug-resistant cancer","volume":"18","author":"Robey","year":"2018","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbcan.2026.189650_bb0845","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/nrc706","article-title":"Multidrug resistance in cancer: role of ATP\u2013dependent transporters","volume":"2","author":"Gottesman","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbcan.2026.189650_bb0850","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1126\/science.1069492","article-title":"Systems biology: a brief overview","volume":"295","author":"Kitano","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.bbcan.2026.189650_bb0855","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2026.189650_bb0860","doi-asserted-by":"crossref","first-page":"703","DOI":"10.4161\/rna.20481","article-title":"The hallmarks of cancer","volume":"9","author":"Gutschner","year":"2012","journal-title":"RNA Biol."},{"key":"10.1016\/j.bbcan.2026.189650_bb0865","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41568-020-00306-0","article-title":"RNA in cancer","volume":"21","author":"Goodall","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbcan.2026.189650_bb0870","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.cell.2011.07.014","article-title":"A ceRNA hypothesis: the Rosetta stone of a hidden RNA language?","volume":"146","author":"Salmena","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2026.189650_bb0875","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/nrg3074","article-title":"Non-coding RNAs in human disease","volume":"12","author":"Esteller","year":"2011","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.bbcan.2026.189650_bb0880","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nrd.2016.246","article-title":"MicroRNA therapeutics: towards a new era for the management of cancer and other diseases","volume":"16","author":"Rupaimoole","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bbcan.2026.189650_bb0885","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/s41565-021-00898-0","article-title":"The current landscape of nucleic acid therapeutics","volume":"16","author":"Kulkarni","year":"2021","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.bbcan.2026.189650_bb0890","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-025-02463-y","article-title":"Advances in RNA-based cancer therapeutics: pre-clinical and clinical implications","volume":"24","author":"Yan","year":"2025","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bbcan.2026.189650_bb0895","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.trecan.2024.06.006","article-title":"Small molecules targeting microRNAs: new opportunities and challenges in precision cancer therapy","volume":"10","author":"Jurj","year":"2024","journal-title":"Trends Cancer"},{"key":"10.1016\/j.bbcan.2026.189650_bb0900","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1038\/s12276-024-01224-z","article-title":"RNA-binding proteins and exoribonucleases modulating miRNA in cancer: the enemy within","volume":"56","author":"Seo","year":"2024","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.bbcan.2026.189650_bb0905","article-title":"MiRNA interplay: mechanisms and therapeutic interventions in cancer","volume":"3","author":"Wang","year":"2024","journal-title":"MedComm \u2013 Oncol."},{"key":"10.1016\/j.bbcan.2026.189650_bb0910","article-title":"Challenges and opportunities in microRNA-based cancer therapeutics","volume":"6","author":"Ju","year":"2025","journal-title":"Cell Rep. Med."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X26001228?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X26001228?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T13:22:45Z","timestamp":1785072165000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304419X26001228"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":182,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S0304419X26001228"],"URL":"https:\/\/doi.org\/10.1016\/j.bbcan.2026.189650","relation":{},"ISSN":["0304-419X"],"issn-type":[{"value":"0304-419X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Post-transcriptional regulation in cancer chemoresistance","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Reviews on Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbcan.2026.189650","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"189650"}}